ReEir
Hongo
About ReEir
ReEir is a research firm that develops global regenerative medicine and cell therapy products for ulcer patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $3.9M
- Funding stage: Seed
- Last round: Seed (Jul 2025)
- Website: re-eir.com
- Phone: +81 036-555-2771
Industries & Categories
Emergency Medicine, Market Research, Medical
Canonical: https://fsome.com/organization/reeir-66111 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.